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CHIP is a cochaperone of Hsp70 that inhibits Hsp70-dependent refolding in vitro. However, the effect of
altered expression of CHIP on the fate of unfolded proteins in mammalian cells has not been determined.
Surprisingly, we found that overexpression of CHIP in fibroblasts increased the refolding of proteins after
thermal denaturation. This effect was insensitive to geldanamycin, an Hsp90 inhibitor, and required the
tetratricopeptide repeat motifs but not the U-box domain of CHIP. Inhibition of Hsp70 chaperone activity
abolished the effects of CHIP on protein folding, indicating that the CHIP-mediated events were Hsp70
dependent. Hsp40 competitively inhibited the CHIP-dependent refolding, which is consistent with in vitro data
indicating that these cofactors act on Hsp70 in the ATP-bound state and have opposing effects on Hsp70
ATPase activity. Consistent with these observations, CHIP overexpression did not alter protein folding in the
setting of ATP depletion, when Hsp70 is in the ADP-bound state. Concomitant with its effects on refolding
heat-denatured substrates, CHIP increased the fraction of nascent chains coimmunoprecipitating with Hsc70,
but only when sufficient ATP was present to allow Hsp70 to cycle rapidly. Our data suggest that, consistent with
in vitro studies, CHIP attenuates the Hsp70 cycle in living cells. The impact of this effect on the fate of unfolded
proteins in cells, however, is different from what might be expected from the in vitro data. Rather than resulting
in inhibited refolding, CHIP increases the folding capacity of Hsp70 in eukaryotic cells.
The 70-kDa heat shock protein Hsc70/Hsp70 is an abundant
cytosolic and nuclear chaperone that assists many protein-
folding events as well as facilitating the proteolytic degradation
of unstable or misfolded proteins (5, 11, 21, 26, 38). These
roles of Hsp70 rely on its ability to bind to short exposed
hydrophobic stretches of substrate polypeptides in an ATP-
regulated fashion. At normal growth temperatures, ATP-
bound Hsp70 exhibits low affinity and fast exchange rates for
substrates, whereas the ADP-bound state has high substrate
affinity but slow exchange rates (9, 20, 32, 33). Hydrolysis of
ATP, and hence conversion of Hsp70 to the ADP-bound state,
is stimulated by substrate binding and by cochaperones of the
Hsp40/DnaJ family (6, 20, 25) through events that are likely to
occur in a synergistic manner (16). At physiologically relevant
Hsp40-Hsp70 ratios (0.1), this synergy may ensure that sub-
strates first bind to Hsp70 and subsequently become tightly
associated with the ADP-bound high-affinity state of Hsp70, so
that refolding of denatured substrates is promoted (16). In
vitro data also show that as Hsp40-Hsp70 ratios increase, the
rate of ATP hydrolysis by Hsp70 accelerates, and this corre-
lates with less efficient refolding of denatured substrates (16).
Consistent with these in vitro data, we demonstrated that
overexpression of Hsp40 in mammalian cells (yielding high
Hsp40-Hsp70 ratios) reduces refolding of the in situ heat-
inactivated reporter protein firefly luciferase (23). In contrast,
when Hsp40 is overexpressed together with Hsp70, an en-
hancement of refolding of luciferase is observed. These exper-
iments raise the surprising possibility that, under stressful con-
ditions, the maximal refolding activity of Hsp70 may require
events that occur in the ATP-bound conformation, perhaps by
taking advantage of the high substrate on-rate under these
conditions, and that rapid conversion to the ADP-bound con-
formation may actually be deleterious to proper refolding, at
least under some circumstances. However, this hypothesis has
not been tested formally.
Two other cochaperones, Hip and Bag-1, act on the chap-
erone activity of Hsp70 in the ADP-bound state, with antago-
nistic effects on the refolding kinetics of the bound substrate.
Both cochaperones bind to the ATPase domain of Hsp70 and
enhance (Hip) or inhibit (Bag-1) protein refolding of Hsp70-
bound substrates in vitro (4, 10, 12, 19, 35, 36). Recently, we
demonstrated that increased expression of Hip in mammalian
cells similarly enhances the refolding of the heat-inactivated
reporter enzyme luciferase (30). Hip also protects luciferase
from irreversible denaturation under conditions of ATP deple-
tion, as would be expected based on in vitro assays of Hip
function. In contrast to the effects of Hip, Bag-1 inhibits Hsp70
chaperone activity in mammalian cells at physiologically rele-
vant concentrations (29), again confirming in vitro observa-
tions of the activity of this cochaperone. These studies also
demonstrate the utility of measuring luciferase folding in cells
as a means to elucidate the function of cochaperones in a
cellular environment.
Yet another regulator of the Hsp70 chaperone, CHIP, was
recently identified, and its effects on Hsp70 have been charac-
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terized in vitro (2). CHIP is a 35-kDa protein that interacts
with the carboxyl terminus of Hsp70 through its amino-termi-
nal domain, which contains three tetratricopeptide repeats
(TPR) and an adjacent charged domain. Two different groups
have shown that CHIP, similar to Hsp40, acts on Hsp70 in the
ATP-bound state; however, in contrast to Hsp40, CHIP inhib-
its the Hsp40-stimulated ATPase activity of Hsp70 (2, 21). In
parallel, CHIP inhibits the refolding of thermally denatured
firefly luciferase in vitro in the presence of Hsp70 and Hsp40 at
a molar CHIP to Hsp40 to Hsp70 ratio of 2:2:1 (2), although its
effects on refolding in mammalian cells have not yet been
tested.
In addition to the TPR domain, CHIP also contains a U-box
(a modified RING finger) at its carboxyl terminus, which sug-
gests a role in ubiquitin-dependent protein degradation (1, 15).
Indeed, overexpression of CHIP in mammalian cells enhances
the degradation of the cystic fibrosis transmembrane-conduc-
tance regulator (CFTR) (21), and recently CHIP has been
shown to be a bona fide E3-ubiquitin ligase (13). However, it
must be noted that the effect of CHIP as an enhancer of
(Hsp70-dependent) protein degradation is substrate specific,
as maturation and degradation of proteins other than CFTR
(such as the transferrin receptor and apolipoprotein B48) are
unaffected by CHIP overexpression (21). Both the U-box do-
main and the TPR domain of CHIP are essential for CFTR
degradation (21). The U-box is, however, dispensable for the
ability of CHIP to inhibit Hsp70 ATPase activity in vitro (21),
suggesting that the degradative effects of CHIP are not caused
simply by a nonspecific inhibition of CHIP on the protein-
folding function of Hsp70.
The effect of CHIP on CFTR degradation seems to depend
only on interaction with Hsp70 and not, for example, with
Hsp40 or Hsp90 (21). In addition, the degradation-promoting
activity is specific for the cochaperone CHIP, as increased
expression of Hip, Hsp40, or Bag-1 has no effect on CFTR
degradation (21), although overexpression of Bag-1 in CHIP-
overexpressing cells may enhance the degradation effect of
CHIP (8). CHIP also interacts with the TPR acceptor site of
Hsp90, which leads to remodeling of the Hsp90 complex (7).
As such, CHIP abolishes the steroid binding activity and trans-
activation potential of the glucocorticoid receptor by enhanc-
ing glucocorticoid receptor ubiquitination and degradation via
the proteasome (7). This action also requires both the TPR
domain of CHIP and its U-box domain, suggesting that the
effect of CHIP on glucocorticoid receptor degradation also
may be uncoupled from the effects of CHIP on the protein-
folding function of Hsp70.
We have investigated the in situ effects of full-length CHIP,
a TPR deletion mutant, and a U-box deletion mutant on the
protein-refolding function of Hsp70. To this end, different
CHIP variants were coexpressed with firefly luciferase in ham-
ster fibroblasts, either alone or combined with Hsp70, Hsp40,
and/or Bag-1. Especially at relatively high CHIP-Hsp70 expres-
sion ratios and in contrast to our expectations, CHIP attenu-
ated the rate of thermal inactivation of luciferase and in-
creased the rate and extent of luciferase refolding at a
permissive temperature. This action required the TRP domain
of CHIP. The U-box domain, however, was dispensable for this
action. Coexpression of Hsp40 acted competitively with the
effect of CHIP on the rate of luciferase inactivation, and dom-
inant-negative constructs of Hsp40 (22) completely abolished
the effects of CHIP on protein folding, indicating that this
activity of CHIP is Hsp70 dependent. In contrast, coexpression
of Bag-1 did not influence the effect of CHIP on thermal
inactivation of luciferase, although it did inhibit the refolding
kinetics, as found previously (29, 30). These studies thus pro-
vide a basis for understanding the importance of the ATP
hydrolysis step in the Hsp70 chaperone cycle in preventing
irreversible protein unfolding under conditions of cellular
stress and emphasize the need to understand both in vitro and
cellular functions of chaperones and cochaperones in order to
assign cellular functions to components of the protein-folding
machinery.
MATERIALS AND METHODS
Plasmids and constructs. pRSVLL/V encodes cytoplasm-localized luciferase
under the control of a Rous sarcoma virus (RSV) long terminal repeat (24). In
some experiments, we used pRSVLL/V-EGFP, which encodes luciferase tagged
at its C terminus with the enhanced green fluorescent protein (EGFP). In
biochemical experiments, luciferase and luciferase-EGFP behave in a similar
manner (data not shown). For expression of CHIP, we used pCDNA3-CHIP,
pCDNA3-CHIP-Myc (Myc tagged), pCDNA3-CHIP-TRP (residues 32 to 145
deleted), and pCDNA3-CHIP-E4 (residues 196 to 303 deleted) (7). Plasmids
pCMV70, pCMV40, pCMV40-1-75 (residues 76 to 340 deleted), and pCDNA-
Bag-1M were used to express Hsp70 (human, inducible form), Hsp40 (also
known as Hdj-1) (22, 23), and the murine 29-kDa isoform of Bag-1, respectively
(4, 29). As a control, we always used the empty vector pSP64 (Promega).
Cell culture, transfections, stress treatments, and luciferase measurements.
Hamster lung fibroblasts (O23) were maintained in Dulbecco’s modified Eagle’s
medium supplemented with 10% fetal bovine serum (Gibco, Paisley, United
Kingdom). Transient transfections with luciferase and (co)chaperone-encoding
plasmids were performed with Lipofectamine according to the manufacturer’s
instructions (Gibco, Paisley, United Kingdom). The plasmid quantity was kept
equal to 10 g/25-cm2 dish by the addition of plasmid pSP64 (Promega), usually
with 1 g of DNA of each relevant plasmid per dish, unless otherwise indicated.
At 48 h after transfection, the medium was replaced with medium containing 20
g of cycloheximide per ml and 20 mM MOPS, pH 7.0. After a 30-min incuba-
tion, cells were heated to inactivate the luciferase. Subsequently, the cells were
reincubated at 37°C to allow reactivation of the luciferase.
For ATP depletion experiments, Chinese hamster ovary (CHO) cells grown in
Ham’s F12 medium supplemented with 10% fetal bovine serum were transferred
to tissue culture tubes and incubated at 37°C in glucose-free Dulbecco’s modified
Eagle’s medium in the presence of 3% fetal bovine serum, 10 mM 2-deoxyglu-
cose, and 20 M carbonyl cyanide m-chlorophenylhydrazone (CCCP) (18). Dur-
ing this incubation, triplicate samples were taken for measurement of luciferase
activity.
To test for effects of (co)chaperone expression on luciferase turnover rates,
cells were incubated in the presence of cycloheximide without heating for up to
6 h at 37°C. At various time points, triplicate samples were taken for the
measurement of luciferase activity as previously described (24).
Western blot analysis and immunofluorescence analysis. Cells were
trypsinized, resuspended in phosphate-buffered saline, and lysed by addition of
sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) sample
buffer and sonication prior to SDS-PAGE and Western blot analysis. CHIP was
detected with polyclonal antiserum raised against the full-length CHIP protein
(2). Hsp70 was detected with a monoclonal antibody specific for the heat-
inducible form of Hsp70 (C92; Stressgen). After incubation with appropriate
secondary antibodies, specific binding was visualized by enhanced chemilumi-
nescence (ECL; Amersham). To measure luciferase solubility, cells were sepa-
rated into Triton X-100-soluble and Triton X-100-insoluble fractions as de-
scribed before (29), and the samples were loaded on SDS–10% polyacrylamide
gels. Since the commercially available antibodies against luciferase are of rather
poor quality, luciferase-EGFP was used in these experiments. A monoclonal
antibody directed against EGFP (8363-2; Clontech) was used for detection of the
fusion protein. For intracellular localization, we used confocal microscopy (Leika
TCS SP2).
Pulse labeling of newly synthesized proteins. CHO cells in 10-cm plates were
transfected with a plasmid expressing a Myc-tagged Hsc70 with or without
pCDNA3-CHIP, as described before (7). At 48 h after transfection, the cells
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were incubated in medium containing [35S]methionine (Amersham, SJ1015) for
10 min at 37°C. The medium was removed, and the cells were immediately lysed
in radioimmunoprecipitation assay (RIPA) buffer containing either apyrase (10
U/ml) or ATP (2.5 mM) plus an ATP-regenerating system on ice. Equal amounts
of lysates were immunoprecipitated with an anti-Myc antibody (Santa Cruz)
under these conditions, and labeled proteins were separated by SDS-PAGE,
followed by autoradiography. For quantification, the amount of nascent polypep-
tides coimmunoprecipitating with Myc-tagged Hsc70 was measured with a phos-
phorimager (Molecular Dynamics 445 SI).
RESULTS
Luciferase degradation is not affected by CHIP and Hsp70
overexpression. In vitro, luciferase is an efficient substrate for
Hsp70, and its refolding by Hsp70 can be influenced by CHIP
(2). In cells, CHIP can target at least one Hsp70 substrate
(CFTR) for proteosome-dependent degradation (21). In addi-
tion, CHIP has been implicated in the ubiquitination of heat-
denatured luciferase in vitro (27). We therefore first tested
whether the rate of luciferase degradation in cells is also in-
fluenced by CHIP. To determine luciferase turnover at 37°C
under conditions in which denaturation of luciferase is mini-
mal, we coexpressed luciferase with CHIP, Hsp70, or both. At
48 h after transfection, the cells were treated with cyclohexi-
mide to inhibit new protein synthesis. Luciferase activity was
monitored for up to 6 h. Under these conditions, luciferase
activity decreased to about 45% of the control in 6 h, indicating
that luciferase has a half-life of about 5.5 h (Fig. 1A). The
coexpression of CHIP or Hsp70 alone or both combined had
no effect on the half-life of luciferase, indicating that neither
protein affects the rate of luciferase degradation in the absence
of thermal stress. In addition, the specific activity of luciferase
was not significantly affected by coexpression of CHIP or
Hsp70 at this temperature (not shown).
We next considered whether CHIP and/or Hsp70 might
preferentially affect the rate of degradation of luciferase when
it has been heat denatured. To test this possibility, transfected
cells were exposed to heat shock at 45°C for 30 min (conditions
which result in denaturation and inactivation of the majority of
luciferase), and the total amount of luciferase was determined
by Western blotting. No loss of luciferase signal was seen
immediately after (H) or 3 h after (HR) heat shock, irre-
spective of overexpression of Hsp70, CHIP, or both (Fig. 1B).
Also, we did not observe the accumulation of slowly migrating
forms of luciferase, which would have been indicative of (chap-
erone-dependent) ubiquitination.
Endogenously, CHIP localizes to the endoplasmic reticulum
of mammalian cells but is also present diffusely in the cytosol
(21). To ascertain that the absence of an effect of ectopically
expressed CHIP on protein degradation is not due to an ab-
normal intracellular localization, we performed confocal mi-
croscopic analysis. As can be seen in Fig. 2, a significant frac-
tion of ectopically expressed CHIP localized to the cytosol
(Fig. 2A and E), where most of the EGFP-tagged luciferase
also resided both before and after heat shock (Fig. 2B and F).
Taken together, and in contrast to the situation in vitro, our
observations indicate that luciferase is not a (major) substrate
for the ubiquitin ligase activity of CHIP in cells, either at 37°C
or when unfolded by heat shock.
Overexpression of CHIP enhances refolding of heat-dena-
tured luciferase. Because luciferase is a thermolabile reporter
protein, measurement of its activity and solubility has proven
to be extremely helpful in unraveling the ability of Hsp70
cochaperones to modify the refolding of denatured proteins in
mammalian cells in situ (22, 23, 28–30). With this approach,
CHIP was transiently coexpressed (Fig. 3A, lane 1) with cyto-
plasm-localized luciferase in O23 hamster fibroblasts, which
constitutively express Hsc70 but not Hsp70. At 48 h after
transfection, the cells were heated for 30 min at 45°C to inac-
tivate luciferase. Cycloheximide was added prior to heat shock
to prevent new protein synthesis during postheat incubation at
37°C to be able to specifically monitor chaperone-dependent
refolding of luciferase. In contrast to what can be expected
from the in vitro data (2), overexpression of CHIP alone led to
a fivefold increase in luciferase refolding within 60 min com-
pared to effects observed in control O23 cells (Fig. 3B). Similar
effects were detected in CHO cells (data not shown).
CHIP overexpression did not cause a general stress response
in the O23 cells used here, as indicated by the fact that we
found no alterations in expression levels of stress-inducible
Hsps such as Hsc70, Hsp70, Hsp90, and Hsp40 within this time
frame (data not shown). This is consistent with previous ob-
servations in MEK293 cells (21) and excludes the possibility
that the observed effects of CHIP on protein refolding are due
FIG. 1. Luciferase degradation and CHIP overexpression. (A) O23
cells were transfected with Hsp70 (solid squares), CHIP (solid trian-
gles) CHIP and Hsp70 (open squares), or a control plasmid (solid
circles) together with pRSVLL/V, encoding firefly luciferase targeted
to the cytoplasm. At 48 h after transfection, the cells were treated with
cycloheximide (CHX) to inhibit new luciferase synthesis, and lucif-
erase activity was measured and plotted relative to the activity prior to
cycloheximide treatment (100%). Data are means  standard errors
of the means from three to four independent experiments performed
in quadruplicate. (B) O23 cells were transfected with Hsp70 (lanes 4 to
6), CHIP (lanes 7 to 9), CHIP and Hsp70 (lanes 10 to 12), or a control
plasmid (lanes 1 to 3) together with pRSVLL/V, encoding firefly lu-
ciferase targeted to the cytoplasm. At 48 h after transfection, the cells
were lysed either immediately (C), directly after a 30-min heat shock at
45°C (H), or 180 min at 37°C after the heat shock (HR), and lucif-
erase expression was measured by Western blotting.
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to global alterations in steady-state levels of Hsps under these
conditions. Overexpression of Hsp70 is also effective in en-
hancing luciferase refolding in the cytosol (22, 23, 28) (Fig.
3B). When CHIP was coexpressed with Hsp70, the luciferase
refolding was not significantly different from that in cells ex-
pressing Hsp70 alone (Fig. 3B), suggesting that the effects of
CHIP on refolding are dependent on the stoichiometry be-
tween CHIP and Hsc70/Hsp70.
Deletion of the U-box domain (residues 190 to 303; Fig. 3A,
lane 3), which is required for CHIP-dependent CFTR degra-
dation (21), had no effect on the ability of CHIP to refold
luciferase (Fig. 3C), consistent with previous observations that
the U-box is not required for CHIP-dependent modification of
Hsp70 ATPase and chaperone activity in vitro (21). In contrast,
deletion of the TPR domain (CHIPTPR: deletion of residues
32 to 145; Fig. 3A, lane 2, and Fig. 3C) abolished the ability of
CHIP to enhance refolding in cells, indicating that the effect of
CHIP depended on interactions with either Hsc70 or Hsp90.
To distinguish between these two possibilities, cells were
treated with geldanamycin (1 g/ml), a drug that displaces
ATP from Hsp90 chaperone complexes, hence impairing its
chaperone activity (31, 34). Geldanamycin reduced the extent
of refolding in control cells (Fig. 3D), indicating that disrup-
tion of the endogenous Hsp90 chaperone network antagonizes
the cellular capacity to refold heat-denatured luciferase in
mammalian cells. Expression of CHIP, however, enhanced re-
folding in the geldanamycin-treated cells to a similar extent as
in nontreated cells (Fig. 3D). These observations indicate that
Hsp90 activity is not needed for the observed effects of CHIP
and imply that enhanced luciferase refolding by CHIP is prob-
ably independent of its ability to bind Hsp90 and alter its
activity.
Enhanced protein refolding by CHIP requires a functional
Hsc/Hsp70 chaperone machine. Previously, we have demon-
strated that expression of a truncated form of Hsp40 (Hsp40-J;
residues 76 to 340 deleted) has a dominant negative effect on
the chaperone activity of Hsc70/Hsp70 (22). To test whether
the effects of CHIP on luciferase refolding are dependent on
Hsp70 function, we coexpressed CHIP and Hsp40-J with lucif-
erase in O23 cells. If the action of CHIP is independent of the
action of Hsc70/Hsp70, coexpression Hsp40-J expression
should result in levels of refolding comparable to that seen in
cells transfected with CHIP alone. However, this was not the
case; when CHIP was coexpressed with Hsp40-J, refolding of
luciferase returned to control levels (Fig. 3E). Hsp40-J expres-
sion alone resulted in levels of refolding even below control
(not shown). Taken together with the preceding experiments,
we can conclude that the effects of CHIP on luciferase refold-
ing require a functional Hsc70/Hsp70 chaperone machine, and
are independent of Hsp90 activity.
Competition between effects of Hsp40 and CHIP on lucif-
erase inactivation. The observed CHIP-mediated enhance-
ment of the Hsc70/Hsp70-dependent chaperone capacity
seems unexpected considering the inhibitory action of CHIP
on the ATPase activity of Hsc70/Hsp70. However, we have
previously found that expression of Hsp40 at levels sufficient to
obtain a relatively high ratio of Hsp40 to Hsc70/Hsp70 in cells
has negative effects on cellular protein refolding (23). Under
these same conditions, the rate of luciferase inactivation dur-
ing heat shock was enhanced (23). As Hsp40 participates in
loading substrates onto Hsp70, one might explain this negative
effect on refolding by arguing that high Hsp40:Hsp70 ratios in
cells might have changed the equilibrium between Hsp70-
bound and Hsp40-bound (non-refolding competent) sub-
strates. However, overexpression of Hsp40 containing a single
point mutation in the HPD motif of its J-domain (Hsp40 H/Q
[28]), which lacks the capacity to interact with Hsp70 family
members (37) but has an intact substrate binding domain (17),
has no effect on protein inactivation and refolding in cells (22;
data not shown). Therefore, the negative effect of Hsp40 on
FIG. 2. Overexpressed CHIP shows partial colocalization with cytosolic luciferase before and after heat shock. O23 cells were transfected with
CHIP and cytoplasmic firefly luciferase-encoding constructs. At 48 h after transfection, the cells were processed for immunohistochemistry and
subsequent confocal microscopic analysis to detect the localization of ectopically expressed CHIP (A and E) and luciferase (B and F) under control
(A to D) and heat shock (E to H) conditions. The cells were counterstained with 4,6-diamidino-2-phenylindole (DAPI) (C and G). Merged
images are shown in panels D and H.
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folding is most likely explained by its ability to enhance the
ATPase activity of Hsp70. Since CHIP has the opposite effect
on Hsp70 (i.e., inhibiting rather than enhancing the ATPase
activity of Hsp70), one may envision that Hsp40 and CHIP
have competitive effects on Hsp70-dependent protein refold-
ing.
As a first step to test this model, we examined the effects of
CHIP or CHIPTPR on the rate of luciferase inactivation in
cells. Indeed, when cells were heated at either 42°C (Fig. 4A)
or 45°C (Fig. 4B), the rate of luciferase inactivation was re-
tarded by CHIP but not by CHIPTPR. This protective effect
of CHIP was about 50% of the protection seen in cells over-
expressing Hsp70 (Fig. 4A and B). Similar observations were
made for luciferase solubility. In unheated control cells, about
10% of the luciferase is recovered in the Triton X-100-insolu-
ble pellet fraction and 90% was soluble, irrespective of chap-
erone overexpression (Fig. 4C, lanes 1 to 9). After heating,
more than 85% of the luciferase ended up in the pellet fraction
of control cells (Fig. 4C, lanes 10 to 12). In cells overexpressing
Hsp70, more luciferase remained soluble and only 50% ap-
peared in the pellet (Fig. 4C, lanes 16 to 18). In cells overex-
pressing CHIP, protection against luciferase insolubility was
also observed; only about 60% of the luciferase ended up in the
pellet under these conditions (Fig. 4C, lanes 13 to 15). These
results, when considered in the context of the sensitizing effect
of Hsp40 on the rate of luciferase inactivation during heat
FIG. 3. Enhanced refolding of heat-denatured luciferase by CHIP is independent of Hsp90 function but dependent on interaction with and
functional activity of Hsp70. O23 cells were transiently transfected with various chaperone-encoding constructs together with pRSVLL/V, encoding
firefly luciferase targeted to the cytoplasm. At 48 h after transfection, the cells were treated with cycloheximide to inhibit new luciferase synthesis,
heated for 30 min at 45°C, and reincubated for 0 to 60 min at 37°C to allow luciferase refolding. Samples were taken at the indicated time points,
and luciferase activity was measured and plotted relative to the activity prior to treatment (100%). Data are means  standard errors of the
means from 3 to 10 independent experiments performed in quadruplicate. (A) Expression levels of full-length (lane 1, arrow) and mutant CHIP
(lane 2, CHIPTPR, arrow; lane 3, CHIPUbox, arrow) after transient transfection. Endogenous CHIP expression is marked with an asterisk;
(B) Luciferase refolding in cells expressing CHIP alone (solid triangles), Hsp70 alone (solid squares), or Hsp70 and CHIP (open squares)
compared to cells transfected with an empty vector (control, solid circles). (C) Luciferase refolding in cells overexpressing full-length CHIP (solid
triangles) compared to CHIP lacking the U-box domain (CHIPUbox; open diamonds), CHIP lacking its TPR domain (CHPTPR; open
triangles), and cells transfected with an empty vector (control; solid circles). (D) Luciferase refolding in cells overexpressing CHIP (triangles)
compared to cells transfected with an empty vector (control; circles) in the absence (solid symbols) or presence of the Hsp90-disrupting agent
geldanamycin (GA; 1 g/ml added 10 min prior to the heat shock) (open symbols). (E) Luciferase refolding in cells overexpressing CHIP
(triangles) or Hsp70 (squares) either alone (open symbols) or when cotransfected with the J-domain of Hsp40 (solid symbols). Cells were
(co)transfected with 1:1 ratios of the plasmids encoding the respective (co)chaperones.
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shock (23), suggest that CHIP and Hsp40 may be competitive
in terms of affecting the chaperone activity of Hsp70.
To assess this hypothesis more directly, we transfected cells
with different ratios of plasmids encoding CHIP and Hsp40
together with luciferase. These cells were heated for 30 min at
45°C and assayed for luciferase activity either immediately
(Fig. 5A and B), after 1 h (Fig. 5C and D), or 3 h at 37°C (Fig.
5E and F). It is clear from these data that Hsp40 and CHIP
acted competitively in terms of luciferase inactivation, insofar
as increasing concentrations of CHIP blocked Hsp40-depen-
dent augmentation of luciferase inactivation and increasing
concentrations of Hsp40 antagonized the ability of CHIP to
suppress luciferase inactivation (Fig. 5A). In addition, the ex-
tent of luciferase reactivation during recovery was similarly
affected (Fig. 5C and E). The level of inactivation after heat
shock closely correlates with the yield of refolding during re-
covery, further supporting the notion that the effects of CHIP,
like those of Hsp40, are mediated via regulation of Hsc70/
Hsp70 (and not Hsp90) by altering its ability to bind to pro-
teins during heat shock and maintain them in a refolding-
competent form. When CHIP was coexpressed with Bag-1, no
competition on the extent of protein inactivation was observed
(Fig. 5B). Consistent with the known effect of Bag-1 to influ-
ence protein refolding via an effect on the Hsp70 in the ADP-
bound state (4, 10, 19, 29, 30, 35, 36), Bag-1 did inhibit the yield
of refolding after heat shock (Fig. 5D and F).
Effects of Hsp70 and CHIP under conditions of cellular ATP
depletion. We previously showed that ATP depletion can re-
sult in inactivation of luciferase, an effect that can be attenu-
ated by Hsp70 or Hip overexpression, but not by overexpres-
sion of Hsp40 (30). These findings are consistent with the
presumed actions of Hsp40 and Hip derived from in vitro
studies. As most of the available Hsp70 will be in the ADP-
bound state under conditions of ATP depletion, Hip, which
regulates the ADP-bound conformation of Hsp70, can still
affect Hsp70 chaperone activity. In contrast, Hsp40, which acts
on Hsp70 in the ATP-bound state, can no longer influence the
Hsp70 chaperone activity under these circumstances. By anal-
ogy, we hypothesized that CHIP also should have no effect on
the rate of inactivation of luciferase under conditions of ATP
depletion if its effects were fully dependent on Hsp70 and
acting to modulate the ratio of Hsp70 that is in the ATP- rather
than ADP-bound conformation.
To test this model, we used CHO cells, as they are more
sensitive to ATP depletion-mediated proteotoxicity than are
hamster lung fibroblasts. CHO cells were depleted of ATP with
2-deoxyglucose plus CCCP, which results in a decline of total
cellular ATP to less than 2% after 60 min, irrespective of
chaperone overexpression (30). Whereas the rate of luciferase
inactivation caused by ATP depletion was attenuated by over-
expression of Hsp70, CHIP had no effect under these condi-
tions (Fig. 6). Similar results were obtained in H9c2 cells,
which are also sensitive to ATP depletion by 2-deoxyglucose
and CCCP (14). These data also indicate that the effects of
CHIP cannot be explained by global effects such as, for exam-
ple, increasing the free pool of Hsp70 available for stress-
related chaperone activities or altering the balance between
degradative and refolding chaperone functions, since such
global effects should result in to protective effects even under
conditions of ATP depletion.
CHIP enhances Hsc70 association with nascent polypeptide
chains in the presence of an ATP-regenerating system. To
explore further whether CHIP affects the ability of Hsc70/
Hsp70 to interact with nonnative proteins in an ATP- or ADP-
dependent manner, we tested the ability of CHIP to influence
the binding of Hsc70 to nascent polypeptide chains. This also
allowed us to determine whether such effects would have an
impact on naturally occurring substrates at physiological tem-
FIG. 4. Thermal inactivation and insolubilization of luciferase is
retarded in CHIP-overexpressing cells. O23 cells were transiently
transfected with constructs expressing Hsp70 (solid squares), CHIP
(solid triangles), CHIP lacking the TPR domain (CHIPTPR; open
triangles), or an empty vector (control; solid circles) together with
constructs encoding (EGFP-tagged) firefly luciferase targeted to the
cytoplasm. At 48 h after transfection, the cells were heated at either
42°C (A) or 45°C (B). Samples were taken at the indicated time points
during heating, and luciferase activity was measured and plotted rel-
ative to the activity prior to treatment (100%). Data are from a
typical experiment performed in quadruplicate. In panel C, unheated
and heated (30 min at 42°C) samples from control cells (lanes 1 to 3
and 10 to 12, respectively), CHIP-overexpressing cells (lanes 4 to 6 and
13 to 15, respectively), and Hsp70-overexpressing cells (lanes 7 to 9
and 16 to 18, respectively) were fractionated, and total cell lysates (T),
the Triton X-100-soluble (S), and insoluble (P) fractions were loaded
on SDS-polyacrylamide gels. Luciferase-EGFP was detected with
EGFP antibodies. Data are from a typical experiment.
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FIG. 5. CHIP acts competitively with Hsp40 but not Bag-1 in affecting luciferase denaturation and refolding. O23 cells were transiently
transfected with different ratios of plasmids encoding Hsp40, CHIP, and an empty vector (A, C, and E) or at a 1:1 ratio with a Bag-1-expressing
plasmid (B, D, and F) together with 1 g of pRSVLL/V, encoding firefly luciferase targeted to the cytoplasm. At 48 h after transfection, the cells
were heated for 30 min at 45°C, and samples were taken immediately after heating (A and B) or 1 h (C and D) or 3 h (E and F) after heating
for measurement of luciferase activity. The activity data are plotted relative to the activity prior to treatment (100%). Data are means from three
to four independent experiments performed in quadruplicate. Error bars were omitted for reasons of clarity but never exceeded 10% of the average
value.
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peratures. To this end, Myc-tagged Hsc70 was cotransfected
with or without CHIP in CHO cells. 48 h after transfection, the
cells were pulse-labeled with [35S]methionine for 10 min to
label nascent chains. Cell lysates were prepared in the presence
of apyrase or an ATP-regenerating system and Myc-Hsc70 and
coimmunoprecipitating labeled proteins were pulled down
with an anti-Myc antibody.
In lysates treated with apyrase, there was an abundance of
labeled nascent proteins that coimmunoprecipitated with Myc-
Hsc70 (Fig. 7, lanes 1 and 3), consistent with the ability of
Hsc70 to bind to nascent chains (3). No coimmunoprecipita-
tion was found in cells without Myc-Hsp70 expression (data
not shown). CHIP had no effect on the extent of coimmuno-
precipitation under this condition (Fig. 7, lane 2, and Table 1),
which is concordant with the absence of an effect of CHIP on
luciferase inactivation during ATP depletion. In the presence
of the regenerating system, allowing active cycling of Hsc70
and hence binding and release of substrates, the amount of
labeled nascent protein that coimmunoprecipitated with Myc-
Hsp70 was drastically reduced, roughly equivalent to back-
ground levels (Fig. 7, lanes 4 and 6, compared with lanes 1 and
3). In cells overexpressing CHIP, however, a threefold increase
in the amount of Hsc70-associated nascent proteins was found
(Fig. 7, lane 5, and Table 1).
To exclude the possibility that this increase was due to bind-
ing of nascent chains to CHIP directly rather than an CHIP-
mediated enhancement of substrate binding to Hsp70, cells
were transfected with a CHIP deletion mutant lacking a func-
tional TPR domain so that it cannot bind to Hsp70. No coim-
munoprecipitation of nascent chains with CHIP was found
(data not shown). These results are consistent with the hypoth-
esis that CHIP, by slowing down the Hsp70 cycle, can enhance
the loading of substrates onto Hsp70. Finally, similar experi-
ments were performed cotransfecting either Hsp40 or Bag-1
together with Myc-tagged Hsc70 (Table 1). As with its effects
on luciferase refolding, Hsp40 had the opposite effect com-
pared to CHIP on the amount of nascent chains coimmuno-
precipitating with Hsp70: in the presence of ATP (but not in
the absence of ATP), the fraction of Hsp70-bound nascent
chains was reduced by Hsp40. Bag-1 had no significant effect
on nascent chain binding of Hsp70 when ATP was present but
significantly reduced the fraction of Hsp70-bound nascent
chains when the experiments were carried out under ATP-
depleted conditions, consistent with its effect as a negative
regulator of Hsp70 via an effect on the Hsp70 in the ADP-
bound state (4, 10, 19, 29, 30, 35, 36).
FIG. 6. Rate of inactivation of luciferase due to ATP depletion is
not retarded by CHIP. CHO cells were transiently transfected with
constructs expressing Hsp70 (solid squares), CHIP (solid triangles),
CHIP lacking the TPR domain (CHIPTPR; open triangles), or an
empty vector (control; solid circles) together with pRSVLL/V, encod-
ing firefly luciferase targeted to the cytoplasm. At 48 h after transfec-
tion, the cells were treated with CCCP in medium containing 2-deoxy-
glucose, which reduces cellular ATP levels to below 2% within 1 h.
Samples were taken at the indicated time points during heating, and
luciferase activity was measured and plotted relative to the activity
prior to treatment (100%). Data are means  standard error of the
mean from three independent experiments performed in quadrupli-
cate.
FIG. 7. CHIP enhances the amount of nascent polypeptide chains
that coimmunoprecipitate with Hsp70 in the presence of an ATP-
regenerating system. CHO cells were transfected with Myc-tagged
Hsc70 with () or without (	) CHIP and pulse-labeled with [35S]me-
thionine at 48 h after transfection. Lysates were prepared in the pres-
ence of apyrase (lanes 1 to 3) or an ATP-regenerating (ATP) system
(lanes 4 to 6). Immunoprecipitation was performed with Myc-Hsp70,
and the precipitated material was run on polyacrylamide-SDS gels.
Arrows indicate the positions of Hsc70 and CHIP. Data are from a
typical experiment (see Table 1 for quantitative data).
TABLE 1. CHIP enhances and Hsp40 reduces the amount of
nascent polypeptide chains that coimmunoprecipitate with Hsp70 in
the presence of an ATP-regenerating systema
Transfection
Relative amt of nascent chains
coimmunoprecipitating with Hsp70  SEM
Without ATP
(apyrase) With ATP
None (control) 1.00  0.08 1.00  0.20
CHIP 1.04  0.14 3.21  0.63
Hsp40 1.15  0.21 0.63  0.11
Bag-1 0.30  0.18 0.80  0.16
a CHO cells were transfected with Myc-tagged Hsc70 alone or together with
CHIP, Hsp40, or Bag-1 and pulse-labeled with [35S]methionine at 48 h after
transfection. Lysates were prepared in the presence of apyrase or an ATP-
regenerating (ATP) system. Immunoprecipitation was performed with Myc-
Hsp70, the precipitated material was run on SDS-PAGE, and the amount of
radioactivity was quantified with a phosphorimager. Averaged data from three to
four independent experiments are provided.
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DISCUSSION
The activity of mammalian Hsp70 is influenced by a variety
of regulators that can determine the ability of the protein to act
as a molecular chaperone in protein refolding assays in vitro.
In addition to the DnaJ family proteins such as Hdj-1/Hsp40,
which can stimulate the activity of the cytoplasmic Hsp70 chap-
erones and thereby enhance the ability of Hsp70 to assist in
refolding of proteins (6, 25), three other classes of proteins
have been identified that interact with Hsp70 to modulate the
Hsp70 reaction cycle. Hip, initially identified in a protein in-
teraction trap assay with the Hsp70 ATPase domain, forms a
complex that enhances Hsp70 chaperone activity in vitro by
stabilizing the ADP-bound conformation of the chaperone
(12). The family of Bag-1 proteins can also associate with the
Hsp70 ATPase domain, yet they inhibit the Hsp70-dependent
refolding of proteins in vitro by facilitating nucleotide ex-
change (4, 10, 19, 35, 36). With our luciferase-based in situ
model, we have been able to demonstrate similar cofactor
dependence of Hsp70-mediated refolding reactions in the
mammalian cytosol and nucleus: overexpression of Hsp40 (to-
gether with Hsp70 overexpression) and Hip enhanced lucif-
erase refolding in cells (22, 23, 30), whereas overexpression of
Bag-1 inhibited this (29, 30). Unexpectedly, however, we now
show that overexpression of CHIP, an inhibitor of the Hsp70
ATPase and chaperone activity in vitro, resulted in enhanced
protein refolding in mammalian cells in situ.
CHIP and protein degradation. Based on the data presented
here, the statement (21) that CHIP is a cochaperone that
converts Hsc70 from a folding machinery into a degradation
factor seems not to be generally true for all Hsp70 substrates.
Although overexpression of CHIP in mammalian cells en-
hances the degradation of CFTR, no effect of CHIP on the
stability of the transferrin receptor or apolipoprotein B48 (21)
or luciferase (this report) has been observed. It therefore re-
mains unclear what determines the fate (refolding or degrada-
tion) of Hsp70-bound substrates. In any case, the degradation-
related properties of CHIP can be clearly dissected from its
ability to affect Hsp70-dependent protein refolding. Whereas
both the U-box domain and the TPR domain of CHIP are
essential for CFTR degradation (21), the U-box is not required
for the ability of CHIP to inhibit Hsp70 ATPase activity in vitro
(21) and for the effects of CHIP on refolding luciferase in
mammalian cells (this report).
Effects of CHIP on refolding unfolded substrates are depen-
dent on functional Hsp70. Our observation that the effects of
CHIP are dependent on the presence of the TPR-domain,
which is required for CHIP-Hsp70 interactions (21) (2, 7),
suggests that the influence of CHIP on refolding is due to
direct modulation of the activity of Hsp70. Yet one could
envision that CHIP overexpression evokes a stress response in
cells leading to an elevation in the level of Hsp70, thereby
increasing the cells’ chaperone capacity. However, in the O23
cells used here and under the experimental conditions used, we
found elevation neither in Hsp70 levels nor in the level of any
other main cytosolic chaperones. Similar results were obtained
when overexpressing CHIP in MEK293 cells (21). Therefore,
the observed effects of CHIP cannot be explained by altering
the steady-state levels of endogenous heat shock proteins in
these experiments. Also, the effects of CHIP are not likely to
be related to altered free pools of Hsp70 under these condi-
tions, as no protection of CHIP overexpression was seen
against denaturation by ATP, a stress that can still be modu-
lated by altered Hsp70 levels (18, 30; this report).
The TPR domains in CHIP are also involved in the inter-
action of CHIP with Hsp90 to remodel the Hsp90 complex (7).
As a result of this remodeling, one can envision that elevated
ratios of CHIP increase the level of free chaperones (Hsp70
or/and Hsp90) available for refolding heat-denatured sub-
strates. Therefore, we treated cells with the drug geldanamy-
cin, which is capable of disrupting the Hsp90 complex (31, 34).
We found that treatment of cells with geldanamycin, by itself,
inhibited refolding in the cytosol. To avoid potential nonspe-
cific effects of geldanamycin, the concentrations of the drug
used were kept low (1 g/ml) and the incubation was short;
hence, they are indicative of some role for constitutively ex-
pressed Hsp90 in refolding heat-denatured luciferase. More-
over, treatment with geldanamycin did not affect the ability of
CHIP-overexpression to enhance luciferase refolding. These
data demonstrate that the CHIP-dependent effects observed in
these studies are not mediated via Hsp90. Finally, the ability of
dominant negative Hsp40 constructs, which block the function
of Hsp70, to abrogate CHIP-dependent refolding (Fig. 2),
strongly supports the contention that the effects of CHIP are
dependent on direct functional interactions with Hsp70.
Reconciliation of Hsp70 modulation by CHIP for in vitro
and cellular refolding activities. It should be emphasized that
our cell data are fully consistent with the mechanism of action
of CHIP on Hsp70 proposed on the basis of in vitro data. The
action of CHIP results in effects on luciferase refolding oppo-
site to those observed with Hsp40, consistent with their respec-
tive and opposing effects on Hsp70 ATPase activity. In addi-
tion, CHIP does not enhance the chaperone capacity of cells
under conditions of ATP-depletion. Similarly, CHIP does not
affect the binding of nascent chains by Hsp70 under conditions
where no ATP is present. CHIP can increase the fraction of
nascent chains coimmunoprecipitating with Hsc70 only when
sufficient ATP is present. The cell data presented here are
therefore in complete agreement with the in vitro data in that
CHIP exerts is effects by acting on the ATP-bound state of
Hsp70 and by decreasing the rate of ATP hydrolysis (2). How-
ever, whereas the mechanism of CHIP’s effects on Hsp70 func-
tion is consistent in in vitro and cellular assays, the conse-
quences of this mechanism differ. In in vitro studies, inhibition
of Hsp70 ATPase activity by CHIP reduces Hsp70-dependent
refolding, whereas overexpression of CHIP in cells leads to a
higher yield of luciferase refolding.
The question remains how to reconcile our observation that
CHIP, an inhibitor of the forward reaction of the Hsp70 cycle
(both in vitro and in cells), enhances protein refolding in cells.
Several laboratories have shown that Hsp40 participates in
vitro with Hsp70 in folding of luciferase in a substoichiometric
concentration (16, 20, 25). However, if the molar ratio of
Hsp40 to Hsp70 is raised above 1:1, the folding reaction is
inhibited (16), possibly because (excess) Hsp40 will reduce
Hsp70 recycling. As a result, substrates will remain bound to
Hsp70 in the ADP-bound state for a longer time and no new
substrates can be captured. Consequently, the pool of Hsp70
that can bind substrates is more rapidly depleted. Especially at
limiting levels of Hsp70, these effects should be most dramatic.
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Indeed, our previous (23) and present studies show a negative
effect on folding when enhancing the forward Hsp70 reaction
by overexpression of Hsp40 alone (but not the mutant Hsp40
H/Q, which cannot interact with Hsp70).
One explanation for the effects of CHIP is that CHIP in-
creases Hsp70 folding activity through a functional interfer-
ence with the interaction between Hsp40 and Hsp70. Thus,
under conditions in which rapid cycling can occur (i.e., in cells
in the presence of ATP), CHIP may merely ameliorate the
consequences of the functional access of Hsp40 to Hsp70 in a
competitive manner, thereby counteracting the effect of Hsp40
on Hsp70 availability. Alternatively, overexpression of CHIP
could have enhanced the likelihood of substrate binding by
Hsp70 in cells by increasing the fraction of Hsp70 in the ATP-
bound form. The ATP-bound form of Hsp70, has a higher
substrate on-rate (9, 20, 32, 33). Although the off-rate of sub-
strates from Hsp70 is even higher when it is in the ATP-bound
state (i.e., lower substrate affinity), attenuating forward cycling
at this step of hydrolysis by CHIP could lead to a better loading
of denaturing substrates to Hsp70. Again, this would have the
highest impact at limiting levels of Hsp70 and it would be
consistent with the negative effect on folding that is observed
when enhancing the forward Hsp70 cycle by excess Hsp40 in
vitro (16) and in cells (23; this report) and the competition
between Hsp40 and CHIP, as reported here. We cannot con-
clude which of these two explanations for the effects of over-
expressing CHIP in cells is the most probable one, as this
highly depends on which of the reactions (ATP hydrolysis or
substrate dissociation) is the fastest in living cells, something
we cannot measure at present.
As the endogenous expression of CHIP is extremely variable
across cell types and since levels of CHIP in cell types such as
skeletal muscle are 20- to 30-fold higher than those observed in
cell types such as CHO or COS (C. Patterson, unpublished
observations), our observations, although obtained with tran-
sient transfection experiments yielding relatively high levels of
overexpression, likely have relevance for protein folding reac-
tions under physiological conditions. In support of this, it was
recently found that cells deficient in CHIP (derived from CHIP
knockout mice) are more susceptible to L-canavanine and heat
shock (Q. Dai and C. Patterson, unpublished data).
With the current data, combined with those published pre-
viously (22, 23, 28–30), we have characterized the cellular ac-
tion of the four regulators of the Hsp70 chaperone cycle known
to date. Results from these studies are sometimes consistent
with in vitro observations (e.g., the effects of Hip and Bag-1)
and are sometimes counterintuitive (e.g., the effects of CHIP
and Hsp40, especially at low Hsp70 concentrations). The cu-
mulative results of these studies indicate both the strengths
and the weaknesses of in vitro assays of chaperone function; in
particular, these studies suggest that in vitro observations un-
derestimate the effects of dynamic changes in Hsp70 confor-
mation that occur in an endogenous milieu of chaperones,
cochaperones, and substrates. In addition, our findings in cells
argue that the role of the ATP-bound conformation of chap-
erones may be far more important in the refolding cycle than
has been estimated by in vitro studies (in which the ATP-
bound conformation is generally considered a quiescent, non-
permissive state), particularly under conditions of cell stress, in
which nucleotide cycling may be rapid and inefficient.
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